Skip to content

Clinical trials

Colorectal Neoplasms, Hereditary Nonpolyposis trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms, Hereditary Nonpolyposis Phase: Not applicable Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20122
20131
20141
20151
20171
20182
20191
20202
20212
20234
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting4
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation2
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kaiser Permanente3
M.D. Anderson Cancer Center3
Ohio State University Comprehensive Cancer Center3
UNC Lineberger Comprehensive Cancer Center2
Boston University1
Duke University1
Fox Chase Cancer Center1
Geisinger Clinic1
HealthPartners Institute1
Jessica D. St. Laurent, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms, Hereditary Nonpolyposis26
Colonic Neoplasms7
Hereditary Breast and Ovarian Cancer Syndrome7
Colorectal Neoplasms6
Neoplastic Syndromes, Hereditary5
Ovarian Neoplasms5
Breast Neoplasms4
Endometrial Neoplasms4
Rectal Neoplasms4
Pancreatic Neoplasms2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.